KD Pharma Group

The company

KD Pharma Group is a worldwide leading omega-3 ingredients producer focused on highly purified omega-3 fatty acids for Pharmaceutical and nutraceutical products. Since the acquisition by capiton IV fund in 2013, KD Pharma has grown from a single-digit revenue business to one of the industry’s largest players.

The transaction

capiton initiated a GP-led single-asset secondary transaction to provide its portfolio company KD Pharma with the necessary Duration and follow-on capital to finance the significant future growth potential expected. The transaction was highly oversubscribed enabling capiton to successfully close the fundraising for its new single-asset continuation fund.

Through a competitive bidding process, the transaction gives existing limited partners of capiton IV fund the option to (partially or fully) sell their stake in KD Pharma or to stay (partially or fully) invested in KD Pharma via a continuation fund and participate in the expected upside potential. The transaction also gives new Investors the opportunity to invest in a very attractive, strongly growing portfolio company. Pantheon and Aberdeen Standard Investments participated as principal new investors alongside other renowned institutions.

Under the new fund structure capiton will continue to manage ist portfolio company KD Pharma as general partner post-closing. capiton is planning to further grow the business organically both via increased internationalisation and product expansion, leveraging KD Pharma’s leading market position, as well as through targeted acquisitions. For this, a new debt package has been secured for KD Pharma Group in parallel to the secondary transaction, as well.

capiton was supported in this secondary transaction by PJT Park Hill (secondary advice), CMS Hasche Sigle, P+P Pöllath + Partners, Stephenson Harwood (legal advice), EY (finance, tax, structuring), Roland Berger (commercial) and Duff & Phelps (Fairness opinion). The new investors were supported by Debevoise & Plimpton and Hogan Lovells (legal advice) as well as Euclid Transactional (W&I insurance). Herter & Co. advised capiton in the debt refinancing process. The transaction was notarized by BMH Bräutigam.

Pressemitteilungen

capiton successfully closes fund VI at €504 million Largest fund in the company’s history Approximately €260 million, including co-investment, already deployed in seven portfolio companies Fund to continue successful deployment in capiton’s focus sectors Pharmaceuticals, Medical Technology, Industrial Technology and Responsible Consumption   Berlin, 24 November 2021 – capiton AG (“capiton”), a leading owner-managed private […]

capiton acquires a stake in Solvis, a sustainable heating pioneer, backing the members of the management team which remain significant shareholders in the company. Solvis is headquartered in Braunschweig, Germany. The company was founded in 1982 and retains its operations in a factory which has been inaugurated as the first zero-emission-facility in Germany in 2002. […]

BIOGGIO, SWITZERLAND – October 4, 2021 – The KD Pharma Group has acquired a 51% stake in Trigal Pharma, a company specialized in clinical research, development and marketing of medical cannabinoids, such as Cannabidiol (CBD) in a highly-purified form. “Trigal has successfully and profitably grown by being a first mover in the API market for […]

capiton acquires the majority stake in Kutterer Mauer AG, backing one of the founders, Mr. Mauer in continuing the growth story of the company. Mr. Mauer as well as other management members invest alongside capiton. Kutterer Mauer AG is a globally operating manufacturer of caps and closure solutions with >450 employees. The Group designs and […]

capiton has successfully closed a new top-up single-asset fund for its fast-growing portfolio company KD Pharma Group („KD Pharma“). This top-up fund will provide KD Pharma with the equity financing for a number of additional strategic investments, in particular add-on acquisitions as well as organic growth initiatives to transfer KD Pharma‘s unique technology and service […]

We are delighted to announce the successful acquisition of 4PICO Litho by Raith. Raith, the leading global manufacturer of precision technology for nanofabrication instrumentation, has expanded its product offering by adding direct write laser lithography systems – manufactured by 4PICO Litho – to its business strategy. In 2004 4PICO Litho, located near Eindhoven (NL) started […]

capiton acquires majority stake in Stürtz Group. Stürtz Group, headquartered in Neustadt (Wied), Germany, is a market-leading designer, producer, and marketer of automated solutions for the window production industry across the globe. The company generated approximately EUR 46 million in sales in 2020 and employs around 270 FTEs across five locations globally. Stürtz’ product portfolio […]

Dec Group acquires Extract Technology We are delighted to announce the successful acquisition of Extract Technology by Dec Group. Extract Technology is a leading provider of containment and aseptic systems for the pharmaceutical, biotech, nuclear and chemical markets. Extract is headquartered in Huddersfield (UK) with a second facility in New Lisbon (US), serving the fast-growing […]

capiton acquires majority stake in Axxence Group The management team of the Axxence Group acquires in a MBO along with capiton the leading natural aroma chemicals manufacturer from its founder, Joost van Neck. Axxence Group, headquartered in Emmerich, Germany, is a leading manufacturer and supplier of natural aroma chemicals (NACs) for the global flavour & […]

EVP Group acquires Group Korott We are delighted to announce the successful acquisition of Group Korott by EVP Group. Group Korott is a leading manufacturer and distributor of vitamins, minerals, natural cosmetics, as well as sport supplements for the Spanish consumer healthcare market. In addition to its store-brand partnering business, Korott has its own brand […]

Engelmann, with headquarters in Wiesloch, Germany, is the leading European manufacturer of smart heat meters for the sub-metering industry.

Wundex Group, with headquarters in Senden, Germany, is a leading home care provider for patients with chronic wounds. The company‘s qualified wound managers provide home care services that enable faster and more effective wound treatment and significantly reduce the workload of general care providers and physicians, backed by an integrated digital platform.